- Report
- March 2024
- 118 Pages
Global
From €4279EUR$4,500USD£3,598GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1189EUR$1,250USD£999GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1189EUR$1,250USD£999GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1189EUR$1,250USD£999GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1426EUR$1,500USD£1,199GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1426EUR$1,500USD£1,199GBP
- Report
- January 2022
- 60 Pages
Global
From €3756EUR$3,950USD£3,158GBP
- Report
- January 2022
- 60 Pages
Global
From €3756EUR$3,950USD£3,158GBP
- Report
- January 2022
- 60 Pages
Global
From €3756EUR$3,950USD£3,158GBP
- Report
- January 2022
- 200 Pages
Global
From €7131EUR$7,500USD£5,996GBP
- Report
- May 2023
- 160 Pages
Global
From €4706EUR$4,949USD£3,957GBP
- Report
- January 2024
- 200 Pages
Global
From €3946EUR$4,150USD£3,318GBP
- Report
- April 2023
- 110 Pages
Global
From €4516EUR$4,750USD£3,798GBP
- Report
- January 2022
- 110 Pages
Global
From €4516EUR$4,750USD£3,798GBP
- Report
- December 2023
- 109 Pages
Global
From €3803EUR$4,000USD£3,198GBP
- Report
- January 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,878GBP
- Report
- December 2024
- 85 Pages
India
From €3328EUR$3,500USD£2,798GBP
- Report
- October 2023
- 190 Pages
Global
From €4279EUR$4,500USD£3,598GBP
- Report
- October 2023
- 78 Pages
United States
From €3328EUR$3,500USD£2,798GBP
- Report
- February 2024
- 73 Pages
Global
From €3500EUR$3,943USD£3,046GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more